Novel use of a radiolabelled antibody against stage specific embryonic antigen for the detection of occult abscesses in mammals

Thakur, Madhukar L

Title: Novel use of a radiolabelled antibody against stage specific embryonic antigen for the detection of occult abscesses in mammals

Full Record
Other Related Research

Abstract

The invention discloses improved reagents containing antibodies against stage specific embryonic antigen-1 antibodies and improved methods for detection of occult abscess and inflammation using the improved reagents.

Inventors:

Thakur, Madhukar L ^[1]

Cherry Hill, NJ

Issue Date:: 1990-01-01

Research Org.:: Thomas Jefferson University

OSTI Identifier:: 867344

Patent Number(s):: 4917878

Assignee:: Thomas Jefferson University (Philadelphia, PA)

Patent Classifications (CPCs):: A - HUMAN NECESSITIES A61 - MEDICAL OR VETERINARY SCIENCE A61K - PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES

Show more

A - HUMAN NECESSITIES A61 - MEDICAL OR VETERINARY SCIENCE A61K - PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
A61K2123/00 - Preparations for testing in vivo
A61K51/1093 - {conjugates with carriers being antibodies}

Show less

DOE Contract Number:: FG02-85ER60295

Resource Type:: Patent

Country of Publication:: United States

Language:: English

Subject:: novel; radiolabelled; antibody; stage; specific; embryonic; antigen; detection; occult; abscesses; mammals; discloses; improved; reagents; containing; antibodies; antigen-1; methods; abscess; inflammation; improved method; specific embryonic; stage specific; improved methods; occult abscess; embryonic antigen-1; embryonic antigen; reagents contain; /424/530/

Citation Formats


                    Thakur, Madhukar L. Novel use of a radiolabelled antibody against stage specific embryonic antigen for the detection of occult abscesses in mammals.  United States: N. p., 1990. 
        Web.

Copy to clipboard


                    Thakur, Madhukar L. Novel use of a radiolabelled antibody against stage specific embryonic antigen for the detection of occult abscesses in mammals.  United States.

Copy to clipboard


                    Thakur, Madhukar L. Mon .  
        "Novel use of a radiolabelled antibody against stage specific embryonic antigen for the detection of occult abscesses in mammals".  United States.  https://www.osti.gov/servlets/purl/867344.

Copy to clipboard


                    
@article{osti_867344,

  title        = {Novel use of a radiolabelled antibody against stage specific embryonic antigen for the detection of occult abscesses in mammals},

  author       = {Thakur, Madhukar L},

  abstractNote = {The invention discloses improved reagents containing antibodies against stage specific embryonic antigen-1 antibodies and improved methods for detection of occult abscess and inflammation using the improved reagents.},

  doi          = {},

  journal      = {},
number       = ,

  volume       = ,

  place        = {United States},

  year         = {1990},

  month        = {1}

}

Copy to clipboard

Patent:

Save / Share:

Export Metadata

Save to My Library

Similar Records in DOE Patents and OSTI.GOV collections:

Novel use of a radiolabelled antibody against stage specific embryonic antigen for the detection of occult abscesses in mammals

Patent Thakur, M L

The invention discloses improved reagents containing antibodies against stage specific embryonic antigen-1 antibodies and improved methods for detection of occult abscess and inflammation using the improved reagents. No Drawings
Direct radiolabeling of antibody against stage specific embryonic antigen for diagnostic imaging

Patent Rhodes, Buck A [Albuquerque, NM]

Antibody against stage specific embryonic antigen-1 is radiolabeled by direct means with a radionuclide for use in detection of occult abscess and inflammation. Radiolabeling is accomplished by partial reduction of the disulfide bonds of the antibody using Sn(II), or using other reducing agents followed by the addition of Sn(II), removal of excess reducing agent and reduction by-products, and addition of a specified amount of radionuclide reducing agent, such as stannous tartrate. The resulting product may be store frozen or lyophilized, with radiolabeling accomplished by the addition of the radionuclide.
Full Text Available
Direct radiolabeling of antibody against stage specific embryonic antigen for diagnostic imaging

Patent Rhodes, B A

Antibodies against stage specific embryonic antigen-1 is radiolabeled by direct means with a radionuclide for use in detection of occult abscess and inflammation. Radiolabeling is accomplished by partial reduction of the disulfide bonds of the antibody using Sn(II), or using other reducing agents followed by the addition of Sn(II), removal of excess reducing agent and reduction by-products, and addition of a specified amount of radionuclide reducing agent, such as stannous tartrate. The resulting product may be stored frozen or lyophilized, with radiolabeling accomplished by the addition of the radionuclide. No Drawings
Method for detecting pathogens attached to specific antibodies

Patent Miles, Robin R.; Venkateswaran, Kodumudi S.; Fuller, Christopher K.

The use of impedance measurements to detect the presence of pathogens attached to antibody-coated beads. In a fluidic device antibodies are immobilized on a surface of a patterned interdigitated electrode. Pathogens in a sample fluid streaming past the electrode attach to the immobilized antibodies, which produces a change in impedance between two adjacent electrodes, which impedance change is measured and used to detect the presence of a pathogen. To amplify the signal, beads coated with antibodies are introduced and the beads would stick to the pathogen causing a greater change in impedance between the two adjacent electrodes.
Full Text Available
Method to directly radiolabel antibodies for diagnostic imaging and therapy

Patent Thakur, Mathew L [Cherry Hill, NJ]

The invention is a novel method and kit for directly radiolabeling proteins such as antibodies or antibody fragments for diagnostic and therapeutic purposes. The method comprises incubating a protein-containing solution with a solution of sodium ascorbate; adding a required quantity of reduced radionuclide to the incubated protein. A kit is also provided wherein the protein and/or reducing agents may be in lyophilized form.
Full Text Available

Similar Records